Terminal de consulta web

cGMP modulation therapeutics for sickle cell disease

cGMP modulation therapeutics for sickle cell disease

Nicola Conran, Lidiane Torres

ARTIGO

Inglês

Agradecimentos: The authors acknowledge grant support from FAPESP Brazil (Grant numbers 2018/08010-9, 2017/14594-0 and 2014/00984-3)

Abstract: Sickle cell disease (SCD) is an inherited disease caused by the production of abnormal hemoglobin (Hb) S, whose deoxygenation-induced polymerization results in red blood cell (RBC) sickling and numerous pathophysiological consequences. SCD affects approximately 300,000 newborns worldwide... Ver mais

FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP

2018/08010-9; 2017/14594-0; 2014/00984-3

Fechado

cGMP modulation therapeutics for sickle cell disease

Nicola Conran, Lidiane Torres

										

cGMP modulation therapeutics for sickle cell disease

Nicola Conran, Lidiane Torres

    Fontes

    Experimental biology and medicine (Fonte avulsa)